Redx Oncology Ltd is a subsidiary of Redx Pharma, a UK-based technology development resource for the global pharmaceutical market.

The application of Redox Switch™ in oncology gives the company the opportunity to deliver multiple development candidates across a range of mechanistic approaches in cancer treatment.

Redx Oncology is taking advantage of the local knowledge base and new biopharmaceutical laboratory infrastructure being created in central Liverpool. The company is working closely with its partners in the University of Liverpool, the Royal Liverpool University Hospital, the Liverpool Cancer Research UK Centre and Liverpool City Council (Liverpool Vision) to achieve its goal of creating new clinical candidates in support of the fight against cancer.

Monitor the research progress of Redx Oncology: Pipeline

Redx Oncology

Address: Duncan Building
Royal Liverpool University Hospital
Daulby Street
L69 3GA

View on map

Phone: 0151 706 4747

Fax: 0151 706 4749

False colour image of Cancer Cells